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Currently MicroRNAs (miRNAs) considered as 
outstanding class of sSmall regulatory non-coding 
RNAs (1). MiRNAs are single-stranded consist of 18
-24 nucleotides (nt) in length transcripts cleaved 
from 70- to 100-nt hairpin precursors by  RNase  III-
type  enzyme and are encoded in the genomes (2). 
The mature miRNA has ability to regulate gene ex-
pression by inhibiting translation and/or by inducing 
degradation of target messenger RNAs (3). Mi-
croRNAs are important to cell function because of 
their ability to control mRNA translation (4).  
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MicroRNAs (miRNAs), one of the most abundant groups of regulatory 
non coding RNAs in multicellular organisms, play important roles in 
many fundamental cellular processes. More than four hundred miRNAs 
have been identified in humans and the deregulated expression of miR-
NA has been also shown in many cancers. Despite the postulated in-
volvement of miRNAs in tumourigenesis, there are only a few exam-
ples  where an oncogene or a tumour suppressor has been identified as a 
miRNA target. Here, we present an in silico analysis of potential miR-
NA- MYC interactions. We showed evidence for the regulation of c-
MYC, one of the most potent and frequently deregulated oncogenes, via 
the predicted binding site in transcriptional and post transcriptional re-
gions. In this work, bioinformatics approach for the prediction and vali-
dation of possible targets for miRNAs has been used. A list of putative 
targets is available and validation of which would be experimentally 
validated. 
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ABSTRACT 
Figure 1: A) MicroRNAs as oncogenes or tumour sup-
pressor genes B) Strategies to target the MYC miRNA 
interplay in cancer. 
According to various studies, miRNAs has critical role(s) 
in various regulatory processes such as embryonic 
development, protein secretion, viral infection, cell self-
renewal/differentiation, cell division and cell proliferation 
(4). Several scientific reports stated that many miRNAs, 
referred to as onco/tumor suppressor miRNAs, play role 
(s) in the development of various human malignancies (5-
8). Aberrant expression of miRNAs involved to 
carcinogenesis by promoting the expression of proto- 
oncogenes or by inhibiting the expression of tumor 
suppressor genes (3). In addition, it is about 50% of genes 
that  encoding miRNAs are located  in cancer associated 
genomic regions (CAGR) or fragile sites (2). Various 
types of leukemia including: acute lymphoblastic 
leukemia (ALL), Acute myeloid leukemia (AML) and 
Chronic lymphocytic leukemia (CLL) has been 
researched extensively from miRNAs point of view and 
currently it has been identified several miRNAs involved 
in all types of leukemia (3). miR-15a-16-1 was the first 
miRNAs identified as regulator of CLL (9). Currently 
there are several miRNAs identified and verified in 
different type of leukemia cancers (10). miRNAsMiRNAs 
not only arouse interest among researchers studying 
molecular mechanism and also gene regulation in 
different type of malignancies but also they theoretically 
represent therapeutic targets. 
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Material and Methods 
 
A: Computational approach to miRNAs 
gene finding 
 
The UTR sequences were retrieved from 
GenBank. The current GeneBank format 
was converted to a FASTA file. In order to 
identify potential and possible hairpin 
structures of miRNAs genes in MYC 
within the area of interest (5’ UTR, 3’ 
UTR, iIntronic and promoter), SCC 
profiler (13) and miPRED (14) online 
classifier (http://www.bioinf.seu.edu.cn/
miRNA) programs were employed.  
For the identification of putative miRNAs 
precursors  in MYC introns CID -
miRNA was used along with the prediction 
of  Dorsha processing s i tes  using 
Microprocessor SVM program (15, 16). 
Hence, search for new miRNAs with computational approaches 
could be useful for better understanding of molecular pathways 
as well as possible new drugs (11). 
MYC plays a role as transcription factor that involved in cell 
cycle and cell growth by acting downstream of many ligand 
membrane receptor complexes and signal transduction 
pathways. (12). MYC is also a proto-oncogene that contributes 
to the genesis of many human cancers (Figure 1) (11). 
Currently there are strong evidences that MYC has critical roles 
in molecular pathways involved in Hodgkin lymphomas and 
also chronic lymphocytic leukemia (CLL) (12). Over expression 
of MYC in B lymphocytes is to be sufficient to increase cell 
growth that could be unlinked from cell proliferation. In 
addition, its central role in the growth programs of T 
lymphocytes.  These evidences demonstrate necessity of study 
on common miRNAs in different leukemia types as possible 
regulator of MYC. In this study, at the first phase we evaluated 
MYC genome; 3' UTR, 5' UTR and also promoter to find 
possible new miRNAs (s). In the second phase, potential of 
common miRNAs in different leukemia types for possible 
interaction with MYC has been evaluated.  
Figure 2: Interactions between MYC-associated 
miRNAs and their potential mRNA targets 
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 miRBase (ht tp: / /www.mirbase.org/
index.shtml) database was also used to 
determine the degree of conservation of 
miRNAs and its precursor sequence along with 
blat search against human genome (17). The 
folding temperature was set to 37°C. We used a 
cut-off value -18 kcal/mol.  
 
B: Computational approach to target 
prediction 
DIANA-microT web server was employed in 
order to find potential target MYC for miRNAs 
(18, 19).   
The prediction was also performed by using 
RNAhybrid (20, 21), targetscan (http://
www.targetscan.org/vert_61/), mirtarbase 
(http://mirtarbase.mbc.nctu.edu.tw/), ElMMo 
( h t t p : / / www.mi rz .un ibas . ch /E lMMo3/
index.php), mirdb (http://mirdb.org/miRDB/), 
MatureBayes(18), pmirp (22) and mirz (23) 
onl ine  tools .  Diana -mirpath  (24)  and 
geneset2miRNA (25) online tools used to find 
the pathways in which MYC-miRNAs is 
involved. Also, for extraction of common 
miRNAs in different types of leukemia cancers 
miRCancer and dbDEMC were developed (25, 
26). The basis of the assumption that the 
epistatically interacting genes operated in the 
same pathway, to search for the co-expression 
of miRNA target genes with miRNA host gene, 
GENEMANIA online tool was used (27).  
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Results and Discussion 
 
The goal of the bioinformatics analysis was to find potential binding sites in the set of human MYC oncogene. In 
humans, as in other animals, the miRNA regulation is accomplished by binding the miRNAs predominantly to the 
3' untranslated region (UTR) of the messenger RNA (28-30). For this reason the investigation and scanning for 
miRNA:mRNA binding sites was limited to this sequences of Homo sapiens. In first, we could not  find any 
region of Myc gene with potentials change to miRNA genes.  After the scanning and filtering of the MYC dataset 
and miRNA genes, positive results for binding sites in sequences. 
(MYC genes) from this set were obtained. Supplementary material presents an arbitrary selection of known MYC-
genes with their predicted miR-regulators of the analysis. The result was then graphed using GENEMANIA to 
show the interactions between MYC-associated miRNAs and their potential mRNA targets. The nodal nature of 
the targets and their overlaps suggests that MYC-associated miRNAs work in concert. We have checkedchecked 
all the human MYC potential interactions and found that they are all located in the 2/3-th region of the 3'UTR. 
However, there is no obligatory region that has been proven so far for the localization of the miRNA binding sites 
within the 3' UTR. miRNAsMiRNA sites also have preferences to the of 3'UTRs sequence composition. Our in 
silico analysis revealed also an additional interaction of potential interest (Supplementary material). 
Deregulation  of  MYC  contributes  to  the  development  a  wide  variety  of human  tumors,  including leukemia  
and neuroblastoma. Counteracting the tumor-promoting activity of MYC is therefore an appealing anticancer 
strategy. Approaches targeting different levels of the MYC pathway are currently being explored. With the 
characterization of the interplay between MYC and miRNAs, yet another layer of targeting opportunities has 
emerged. Thus  the rapidly  growing  understanding  of  the biology of miRNAs in cancer as well as the 
development in RNA-mediated therapeutic  approaches  in  recent  years promises  new,  exciting  modes  of  
specific targeting in cancer.  
More than 28000  human miRNAs have been identified so far and bioinformatics analyses predict that the total 
number may be increased. More than 2000 miRNAs have been already correlated with cancer. Moreover, the exp- 
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ression profile of miRNAs from cancer tissues 
has been suggested to be prognostic concerning 
the speed of cancer development and its malig-
nancy. A correlation between the expression of 
particular miRNAs and their effects on target on-
cogenes followed by tumourigenesis is beginning 
to gain evidence. Of particular interest is the pos-
sibility that the growth of cancer cells can be re-
pressed by artificial modulation of the level of 
miRNAs. Despite the accelerated research interest 
in the miRNA-regulation, there are only a few 
examples where an oncogene or a tumour sup-
pressor has been identified as a miRNA target and 
the regulatory  
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connection validated. Our results indicate that the correlation of the MYC gene, which is one of the critical 
oncogenes, is modulated by numbers of miRNAs, expanding the numbers of validated oncomirs. 
Since the significant increase of miRNA targets, all previous validations (including some "oncomirs") have 
been gathered by Sethupathy et al, in a database called TarBase (31).  
Although now there are many programmesprograms established for the computational prediction of miRNA 
targets(32), the large number of predicted targets makes it difficult to choose the best candidates for further 
experimental verification in a biological system. The advantage of our bioinformatics approach is the possibil-
ity of relatively fast, manual scanning of the secondary structures formed by analysed pairs of putative interac-
tors through the use of the RNAfold format. It is worth noticing, that in the results list of our scanning im-
portant oncogenes can be found, that have already been proven as targets for particular miRNA (see Additional 
file). Based on our analysis it is not possible to specify which member(s) of the miRNAs family is (are) re-
sponsible for the down-regulation of MYC.  
MYC is one important oncogene with the ability to induce both cell proliferation and apoptosis (33). Moreo-
ver, MYC  regulates the transcription of miRNAs from miR-17 cluster and two of them (miR-17-5p and miR-
20) regulate transcription factor E2F1 at the translational level (34), which is also transcriptionally activated by 
MYC (35). A large number of potential miRNA target sites in human oncogenes has been proposed and pre-
sented here based on an in silico analysis. Targets for different oncomirs, experimentally validation of which 
would be of special interest, are needed. We must design the "gold-standard" method to experimentally vali-
date miRNA::target interactions. The miRNAs that are encoded by miRNAs family are conserved between 
mammalian species, both at the sequence level and at their temporal expression patterns, which probably indi-
cates their general role in gene regulation (36). The MYC, on the other hand, is one of the most potent and fre-
quently deregulated oncoproteins in human cancers (37, 38); therefore its deregulation is regarded as a hall-
mark of many cancers (39). 
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